This lack of official recognition by the Medicines and Healthcare Products Regulatory Agency (MHRA) means the manufacturing standards, ingredient purity, and long-term biological effects havent undergone the same rigorous scrutiny as established medical treatments
GLP-1 Microdosing Chart & Schedule According to a 2,700-person real-world study presented at the 2025 European Congress on Obesity, participants achieved an average 16% weight loss over 64 weeks at microdose levels of semaglutide: Microdosing GLP-1 Weight Loss Results Microdose GLP-1 yields 5-10% body weight loss in year one versus 15-20% with full-dose treatment plans
The problem is variability: not all compounders meet that standard, and patients often cannot easily verify which ones do
Musculoskeletal injuries of this nature can occur during both sporting and everyday activities
Further analysis (Sanofi, data on file
The peptide is engineered with a fatty-acid moiety to extend its circulation time (half-life ~6 days), allowing for once-weekly dosing [2]